Revision and 90-day mortality following hip arthroplasty in patients with inflammatory arthritis and ankylosing spondylitis enrolled in the National Joint Registry for England and Wales.
Laura L MillerDaniel Prieto-AlhambraLea Trela-LarsenJ Mark WilkinsonEmma M ClarkAshley W BlomAlexander J MacGregorPublished in: Hip international : the journal of clinical and experimental research on hip pathology and therapy (2021)
The revision risk in HA performed for all types of inflammatory arthritis is similar to that for HA performed for OA. The 3-fold increased risk of 90-day mortality in patients with RA compared with OA highlights the need for active management of associated comorbidities in RA patients during the perioperative period.
Keyphrases
- ankylosing spondylitis
- rheumatoid arthritis
- disease activity
- total hip arthroplasty
- total knee arthroplasty
- end stage renal disease
- cardiovascular events
- oxidative stress
- ejection fraction
- chronic kidney disease
- systemic lupus erythematosus
- risk factors
- prognostic factors
- patients undergoing
- cardiac surgery
- quality improvement
- type diabetes
- patient reported outcomes
- acute kidney injury
- idiopathic pulmonary fibrosis